✦ LIBER ✦
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial
✍ Scribed by David A. Morrow; Benjamin M. Scirica; Keith A.A. Fox; Gail Berman; John Strony; Enrico Veltri; Marc P. Bonaca; Polly Fish; Carolyn H. McCabe; Eugene Braunwald
- Book ID
- 116191836
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 329 KB
- Volume
- 158
- Category
- Article
- ISSN
- 1097-6744
No coin nor oath required. For personal study only.